The a16z Show30 Mar 2020

The Hustler's Guide to Nursing Jobs

This is the next cycle (Q1 2020) of Hustlin' Tech, a podcast series (from the a16z Podcast) about technology platforms that create opportunities for people. Recorded right before the coronavirus pandemic, these next 3 episodes touch on many things that are top of mind right now: from the profession of nursing; to taking care of the elderly; to fighting bureaucracy to get money and time back (and to get help delaying utility bills and rent payments that are eligible for an extension or waiver of late fees due to the coronavirus crisis).

Episode #4, “The Hustler’s Guide to Nursing Jobs” features:

Iman Abuzeid, MD, CEO and co-founder of Incredible Health, a hiring platform for nurses in the U.S. used by hospitals and health systems that helps hospitals find nurses faster, offers free continuing education to nurses everywhere, and puts nurses at the center.
Stephanie Anyanwu, RN, who found her nursing job on the platform and also journeyed to the U.S. from abroad;

...both interviewed by Ben Horowitz and Shaka Senghor.

You can find the first cycle of this series (Q4 2019) -- including more about the what and the why -- here.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1000)

Who Grades the AI Models? | Ben Horowitz & Rayan Krishnan

a16z’s Erik Torenberg, Ben Horowitz, and Jennifer Li sit down with Vals founder and CEO Rayan Krishnan to discuss one of AI’s increasingly difficult problems: how do you actually measure whether a mod...

9 Sep 39min

OpenAI Researchers on the Future of Mathematical Reasoning

a16z Infra Partner Lisha Li sits down with OpenAI mathematicians Mehtaab Sawhney and Mark Sellke to discuss how quickly AI’s mathematical capabilities are advancing, what recent results reveal about m...

8 Sep 1h 5min

Can Open Source Keep AI Power From Concentrating?

MTS host Sophia Dew visits the Open Source AI Summit in San Francisco to ask researchers and founders across the AI stack a central question: can open source prevent AI power from concentrating in the...

7 Sep 8min

Your AI Doctor Is Coming | Julie Yoo

a16z General Partner Julie Yoo joins MTS host Sophia Dew to explain why she believes healthcare could benefit more from AI than almost any other industry, and why decades of slow technology adoption m...

6 Sep 27min

Aaron Levie on Why Open AI Wins

Box co-founder and CEO Aaron Levie joins MTS hosts Theo Jaffee and Sofia Puccini to make the case for open-weight AI, unpack the economics of open versus closed models, and explain why he believes mor...

5 Sep 31min

Fei Fei Li: The Race to Build World Models For AI

World Labs co-founders Fei-Fei Li, Justin Johnson, and Ben Mildenhall join a16z General Partner Martin Casado to discuss Atlas, their latest world model, and what it reveals about the pursuit of spati...

4 Sep 44min

The $100B Niches Hiding Inside Payments

Erik Torenberg is joined by a16z General Partner Alex Rampell and Affirm Co-Founder and CEO Max Levchin for a conversation on 25 years of fintech, from the early days of digital payments to the origin...

3 Sep 1h

Inside Moderna’s Personalized Cancer Vaccine

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment...

2 Sep 40min